Abstract:Crystals of the [SbBr3(MMBZT)2] (1) complex (MMBZT = N-methyl-2-mercaptobenzothiazole) were grown from acetonitrile/methanol of the filtrate derived from the reaction between 3-methyl-2-mercaptobenzothiazole (MMBZT) in methanol, with antimony(III) bromide in acetonitrile. The crystal structure of 1 (C16H14Br3N2S4Sb) was determined by X-ray diffraction at 100(2) K, in space group P-1, with a = 10.738(2) Å, b = 11.387(3) Å, c = 11.439(3) Å, α = 62.764°, β = 63.36(2)°, γ = 85.074(2)°, and Z = 2. The geometry around the metal center of complex 1 is square pyramidal, with two sulfur atoms from thione ligands and three bromide anions around Sb(III). Complex is monomer. The equatorial plane is formed by two sulfur and two bromide atoms in complex, in a cis-S, cis-Br arrangement. The in vitro cytotoxicity against leiomyosarcoma cells (LMS) of antimony(III) bromide complexes with thioamide ligands with formulae: [SbBr3(MMBZT)2] (1), [SbBr3(TU)2] (2), [SbBr3(MMI)2] (3), {[SbBr2(MBZIM)4]+·[Br]−·H2O} (4), {[SbBr2(μ2-Br)(MMBZIM)2]2} (5), {[SbBr2(μ2-Br)(EtMBZIM)2]2·MeOH} (6), {[SbBr3(μ2-S-tHPMT)(tHPMT)]n} (7), {[SbBr2(μ2-Br)(PYT)2)n} (8), {[SbBr2(μ2-Br)(MTZD)2]n} (9), and {[SbBr5]2−[(PMTH2+)2]} (10) (where TU = thiourea, MMI = methylimidazole, MBZIM = 2-mercaptobenzimidazole, MMBZIM = 2-mercapto-5-methyl-benzimidazole, EtMBZIM = 5-ethoxy-2-mercaptobenzimidazole, tHPMT = 2-mercapto-3,4,5,6-tetrahydro-pyrimidine, PYT = 2-mercaptopyridine, MTZD = 2-mercapto-thiazolidine, and PMTH = 2-mercaptopyrimidine) were evaluated. Complex 8 shows the strongest activity against LMS cells with IC50 value 1.7 ± 0.1 μΜ. The results are compared with their activity against human cervix carcinoma cell lines. Complexes 1, 6–9 were also tested for their inhibitory activity upon the catalytic peroxidation of linoleic acid to hydroperoxylinoleic acid by the enzyme lipoxygenase. Computational studies using multivariate linear regression and considering biological results (50% inhibitory concentration, IC50) as dependent variables derived a theoretical equation for IC50 values of the complexes studied. The calculated IC50 values are compared adequately with the experimental inhibitory activity of the complexes measured.

Synthesis, Structure, and in Vitro Antiproliferative Activity of Cyclic Hypervalent Organobismuth(iii) Chlorides and Their Triphenylgermylpropionate Derivatives

STUDIES ON CONDENSED HETEROCYCLIC COMPOUNDS. XX. SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF NOVEL 6-ARYL-3-(1-P-CHLOROPHENYL-5-METHYL-1,2,3-TRIAZOL-4-YL) -S-TRIAZOLO3,4-B-1,3,4- THIADIAZOLES

Bismuth(III) bromide-thioamide complexes: synthesis, characterization and cytotoxic properties

Synthesis, Characterization and in Vitro Antitumor Activity of Some Arylbismuth Triphenylgermylpropionates and Crystal Structures of (4-Brc6h4)3bi(o2cch2ch2geph3)2 and (4-Brc6h4)3bi[o2cch(ch3)ch2geph3]2

Facile synthesis and antifungal evaluation of hypervalent organoantimony(III) and -bismuth(III) thioates with tridentate C,N,C-coordinating ligands

Synthesis, Characterization, and Biological Investigation of Antimony(III) Halide Complexes With Different Coordination Architectures Constructed From Thiophene Thiosemicarbazones

Synthesis, Characterization, Biological Activity, and Topological Studies

Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions

New 3-[(4-hydroxy-6-methly-2(1h)-pyridinones)-3-yl]-4-substituted-(1h)1,2,4- Triazole-5-Thiones: Efficient Synthesis, X-Ray Crystallographic Analysis, and Antitumor Activity

ANTITUMOR AND GASTROPROTECTIVE SCREENING OF SOME NOVEL ORGANIC DERIVATIVES OF BISMUTH

In Vitro and in Vivo Anticancer Activities of Bi(III) 2-Thiazolecarboxaldehyde Thiosemicarbazone Complex

SYNTHESIS, SPECTROSCOPIC CHARACTERIZATION, AND IN VITRO ANTITUMOR ACTIVITY OF TETRAPHENYLANTIMONY DERIVATIVES OF ANALOGUES OF DEMETHYLCANTHARIDIN AND DEMETHYLDEHYDROGEN-CANTHARIDIN

Study on single crystal structure of the antimony(III) bromide complex with 3-methyl-2-mercaptobenzothiazole and biological activity of some antimony(III) bromide complexes with thioamides

Synthesis and Structure of 5-Methyl-9-(trifluoromethyl)-12H-quino[3,4-b][1,4]benzothiazinium Chloride as Anticancer Agent

Synthesis, crystal structure, and in vitro biological evaluation of bismuth (III) complexes incorporating pyrazinohydrazide‐derived Schiff bases

Some Transformations of 2-Thioxo-2,3-Dihydro-1H-Spiro-[Benzo[h]Quinazoline-5,1′-Cycloheptan]-4(6H)-One and the Antibacterial and Antitumor Properties of the Compounds Synthesized

Synthesis, Characterization and Cytotoxicity of Some Triarylbismuth(V) Di(N-P-Toluenesulfonyl) Aminoacetates and the Crystal Structure of (4-Ch3c6h4so2nhch2co2)(2)bi(c6h4cl-(4))(3)

New thiazole derivatives: Synthesis, X-ray crystal structure, Hirshfeld surface analysis, and biological evaluations as potential antimicrobial and antitumor agents

Structural manifestations and biological screening for newly synthesized heteroleptic bismuth(V) bis-carboxylates

Synthesis, Crystal Structure and Antitumor Activity of Novel 5-Chloro-β-carboline Derivatives

Synthesis and in vitro antitumor activity of some triarylantimony di(N-phenylglycinates)